Design and Preparation of Solid Lipid Nanoparticle (SLN)-Mediated DNA Vaccines

Methods Mol Biol. 2022:2412:355-366. doi: 10.1007/978-1-0716-1892-9_18.

Abstract

Increasing application of nucleic acid vaccines is driving demand for new delivery systems to improve stability and efficacy of DNA vaccines. Solid lipid nanoparticles (SLN) are a particulate carrier system composed of a solid lipid core and a cationic lipid surface suitable for binding negatively charged DNA. SLN delivery systems can be used to bind DNA resulting in an SLN/DNA complex (termed "lipoplex") which can be used as a potential vaccine.In this chapter, the methodologies associated with the use of SLNs as a DNA vaccine nanocarrier are discussed. First, requirements for an effective experimental lipoplex vaccine are discussed along with current and historical examples. Then, flowcharts for design and synthesis of lipoplex vaccines are outlined, followed by detailed materials and methods for synthesis and characterization of lipoplex vaccines.

Keywords: DNA vaccine; Lipoplex; Particulate carrier systems; SLN; Solid lipid nanoparticle.

MeSH terms

  • DNA / genetics
  • Drug Carriers
  • Lipids
  • Liposomes*
  • Nanoparticles*
  • Nucleic Acid-Based Vaccines
  • Particle Size
  • Vaccines, DNA

Substances

  • Drug Carriers
  • Lipid Nanoparticles
  • Lipids
  • Liposomes
  • Nucleic Acid-Based Vaccines
  • Vaccines, DNA
  • DNA